Side-by-side financials for CDLX and NBIS. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CDLX | NBIS |
|---|---|---|
| Market cap | - | $58.79 B |
| US-listed rank | - | #285 |
| Revenue (latest FY) | $233.27M | $529.80M |
| Net income (latest FY) | -$104.00M | $82.50M |
| Net margin | -44.6% | 15.6% |
| P/E (trailing FY) | - | 712.6 |
| SEC filings | 1,000 | 445 |
In their latest fiscal years, Cardlytics, Inc. reported $233.27M in revenue while Nebius Group N.V. reported $529.80M.
Full pages: Cardlytics, Inc. and Nebius Group N.V., or browse the full rankings.